Abstract
Malignant neoplasms, other than squamous and adenocarcinoma, infrequently involve the uterine cervix but nevertheless present in cervical cytologic preparations. Most often these tumors are uncommon gynecologic primaries arising in the uterine corpus or adnexa that appear in the cervical preparation, either as exfoliated cells, or via direct sampling of tumors that involve the cervix or vagina by direct extension. Secondary or metastatic tumors to the uterine cervix are seen rarely, owing to the nature of the lymphatic drainage and low vascularity of the cervix. In general, a definitive classification of the tumors described in this chapter may not be possible on cytologic preparations alone because of limited sampling and cytomorphologic overlap with other entities, creating interpretation pitfalls. However, familiarity with these entities is useful when unusual tumor morphology is encountered. Recognition of these rare tumors may help decrease the potential for misinterpretation and allow for more appropriate patient management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bonfiglio TA. Uncommon tumors of the cervix, vagina and uterine corpus. In: Bonfiglio TA, Erozan YS, editors. Gynecologic pathology. Philadelphia: Lippincott-Raven; 1997. p. 145–56.
Ioffe O, Henry MR. The uterine cervix. In: Silverberg SG, DeLellis RA, Frable WJ, LiVolsi VA, Wick MR, editors. Principles and practice of surgical pathology and cytopathology, vol. 2. 4th ed. New York: Churchill Livingstone; 2006. p. 1831–84.
DeMay RM. The pap smear in the art and science of cytopathology, vol. 1. 2nd ed. Hong Kong: ASCP Press; 2012. p. 1–197.
Khalbuss WE, Pantanowitz L, Monaco SE. Cytomorphology of unusual primary tumors in the Pap test. Cytojournal. 2013;10:17.
Kumar NB, Hart WR. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer. 1982;50:2163–9.
Witkiewicz AK, Wright TC, Ferenczy A, Ronnett BM, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s pathology of the female genital tract. 6th ed. New York: Springer; 2011. p. 254–303.
Steeper TA, Piscioli F, Rosai J. Squamous cell carcinoma with sarcoma-like stroma of the female genital tract. Clinicopathologic study of four cases. Cancer. 1983;52:890–8.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. Chapter 5. Tumours of the uterine corpus. In: WHO classification of tumours of the female reproductive organs. 4th ed. Lyon: IARC; 2014.
Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004;93:27–33.
Park HJ, Choi YM, Chung CK, Lee SH, Yim GW, Kim SW, et al. Pap smear screening for small cell carcinoma of the uterine cervix: a case series and review of the literature. J Gynecol Oncol. 2011;22:39–43.
Stoler MH, Mills SE, Gersell DJ, Walker AN. Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol. 1991;15:28–32.
Miles PA, Herrera GA, Mena H, Trujillo I. Cytologic findings in primary malignant carcinoid tumor of the cervix, including immunohistochemistry and electron microscopy performed on cervical smears. Acta Cytol. 1985;29:1003–8.
McCluggage WG, Sumathi VP, Nucci MR, Hirsch M, Dal Cin P, Wells M, et al. Ewing family of tumours involving the vulva and vagina: report of a series of four cases. J Clin Pathol. 2007;60:674–80.
Rajwanshi A, Srinivas R, Upasana G. Malignant small round cell tumors. J Cytol. 2009;26:1–10.
Garcia MG, Deavers MT, Knoblock RJ, Chen W, Tsimberidou AM, Manning JT, et al. Myeloid sarcoma involving the gynecologic tract. A report of 11 cases and review of the literature. Am J Clin Pathol. 2006;125:783–90.
Kuroda N, Wada Y, Inoue K, Ohara M, Mizuno K, Toi M, et al. Smear cytology findings of large cell neuroendocrine carcinoma of the uterine cervix. Diagn Cytopathol. 2013;41:636–9.
Reis-Filho JS, Fillus Neto J, Schonemann E, Sanderson A, Schmitt FC. Glassy cell carcinoma of the uterine cervix. Report of a case with cytohistologic and immunohistochemical study. Acta Cytol. 2001;45:407–10.
Matthews-Greer J, Dominguez, Malagon H, Herrera GA, Unger J, Chanona-Vilchis J, Caldito G, et al. Human papillomavirus typing of rare cervical carcinomas. Arch Pathol Lab Med. 2004;128:553–6.
Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. AJSP. 2007;31:664–72.
Granter SR, Lee KR. Cytologic findings in minimal deviation adenocarcinoma (adenoma malignum) of the cervix. A report of seven cases. Am J Clin Pathol. 1996;105:327–33.
Lim KT, Lee IH, Kim TJ, Kwon YS, Jeong JG, Shin SJ. Adenoma malignum of the uterine cervix: clinicopathologic analysis of 18 cases. Kaohsiung J Med Sci. 2012;28:161–4.
Ki EY, Byun SB, Park JS, Lee SJ, Hur SY. Adenoma malignum of the uterine cervix: report of four cases. WJSO. 2013;11:168.
Hata S, Mikami Y, Manabe T. Diagnostic significance of endocervical glandular cells with “golden yellow” mucin on Pap smear. Diagn Cytopathol. 2002;27:80–4.
Casey MB, Caudill JL, Salomao DR. Cervicovaginal (Papanicolaou) smear findings in patients with malignant mixed mullerian tumors. Diagn Cytopathol. 2003;28:245–9.
Sharma NK, Sorosky JI, Bender D, Fletcher MS, Sood AK. Malignant mixed mullerian tumor (MMMT) of the cervix. Gynecol Oncol. 2005;97:442–5.
Thomas MB, Wright JD, Leiser AL, Chi DS, Mutch DG, Podratz KC, et al. Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era. Gynecol Oncol. 2008;109:335–9.
Stewart 3rd J, Bevans-Wilkins K, Ye C, Kurtycz DF. Clear-cell endocervical adenocarcinoma in a 19-year-old woman. Diagn Cytopathol. 2006;34:839–42.
Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994;84:404–8.
Massoni EA, Hajdu SI. Cytology of primary and metastatic uterine sarcomas. Acta Cytol. 1984;28:93–100.
Masand RP, Euscher ED, Deavers MT, Malpica A. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol. 2013;37:1635–47.
Lemoine NR, Hall PA. Epithelial tumors metastatic to the uterine cervix. Cancer. 1986;57:2002–5.
McCluggage WG, Hurrell DP, Kennedy K. Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases. Am J Surg Pathol. 2010;34:735–41.
Perez-Montiel D, Serrano-Olvera A, Salazar LC, Cetina-Perez L, Candelaria M, Coronel J, et al. Adenocarcinoma metastatic to the uterine cervix: a case series. J Obstet Gynaecol Res. 2012;38:541–9.
Gupta N, Dudding N, Smith JFH. Cytomorphological features of extragenital metastases in SurePathTM cervical liquid-based cytology: a series of eight cases. Cytopatholgy. 2013;24:123–8.
Fiorella RM, Beckwith LG, Miller LK, Kragel PJ. Metastatic signet ring carcinoma of the breast as a source of positive cervicovaginal cytology. A case report. Acta Cytol. 1993;37:948–52.
Yamamoto T, Mori T, Matsushima H, Sawada M, Kitawaki J. Late, isolated metastasis from poorly differentiated gastric cancer to the uterine cervix. Gynecol Oncol Case Rep. 2014;8:17–20.
Childs AJ, Burke JJ, Perry MY, Check WE, Gallup DG. Recurrent colorectal carcinoma detected by routine cervicovaginal. Papanicolaou smear testing. J Low Genit Tract Dis. 2005;9:236–8.
Zulfiqar M, Liu S, Shi D, Madan S, Jacques S, King L, et al. Metastatic colorectal adenocarcinoma in cervicovaginal cytology specimens confirmed by immunocytochemical stains on liquid base specimens: two study cases with review of the literature. CytoJournal. 2013;10:9.
Takashina T, Onto M, Kanda Y, Sagae S, Hayakawa O, Ito E. Cervical and endometrial cytology in ovarian cancer. Acta Cytol. 1988;32:159–62.
Takashina T, Ito E, Kudo R. Cytologic diagnosis of primary tubal cancer. Acta Cytol. 1985;29:367–72.
Layfield LJ, Jones C, Hirschowitz S. Statistical analysis of cytologic features useful in separation of metastatic urothelial carcinoma from other metastatic epithelial malignancies. Diagn Cytopathol. 2003;29:334–8.
Sigel CS, Park KJ, Fine SW, Lin O. Urothelial carcinoma involving vaginal specimens from patients with neobladder: a potential pitfall in diagnostic cytopathology. Diagn Cytopathol. 2012;40:168–72.
Setia N, Goulart RA, Leiman G, Otis CN, Modem R, Pantanowitz L. Cytomorphology of cervicovaginal melanoma: ThinPrep versus conventional Papanicolaou tests. Cytojournal. 2010;7:25.
Simões M, Cunha V, Nabais H, Riscado I, Jorge AF. Primary malignant melanoma of the uterine cervix – case report and review. Eur J Gynaecol Oncol. 2011;32:448–51.
Harris NL, Scully RE. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. Cancer. 1984;53:2530–45.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tabbara, S.O., Khalbuss, W.E. (2015). Other Malignant Neoplasms. In: Nayar, R., Wilbur, D. (eds) The Bethesda System for Reporting Cervical Cytology. Springer, Cham. https://doi.org/10.1007/978-3-319-11074-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-11074-5_7
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11073-8
Online ISBN: 978-3-319-11074-5
eBook Packages: MedicineMedicine (R0)